Reduction in High Rates of Antibiotic-Nonsusceptible Invasive Pneumococcal Disease in Tennessee after Introduction of the Pneumococcal Conjugate Vaccine
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Invasive pneumococcal disease (IPD) is a burgeoning problem, with rates of antibiotic-nonsusceptible IPD, in particular, increasing during the past decade. One measure to combat IPD is vaccination with the recently introduced 7-valent pneumococcal conjugate vaccine (PCV). METHODS: To evaluate the effects of the introduction of PCV in 2000 on the epidemiology of antibiotic-nonsusceptible IPD, a database of IPD cases from January 1995 through December 2002 identified through active surveillance in 5 Tennessee counties was examined. For each case, clinical data were collected, and antibiotic susceptibility testing and serotyping were performed on available isolates. RESULTS: Among children younger than 2 years, IPD rates peaked at 235 cases per 100,000 in 1999 before decreasing, after PCV licensure, to 46 cases per 100,000 in 2002 (P<.001). The proportion of penicillin-nonsusceptible IPD isolates from this age group declined from 59.8% in 1999 to 30.4% in 2002 (P<.01). After 2001, similar decreases in IPD rates and in the proportion of antibiotic-nonsusceptible isolates recovered were seen among persons aged 2 years and older (P<.01). Rates of IPD due to PCV-associated serotypes declined after PCV introduction in all age groups (P<.001), whereas the rate of IPD due to nonvaccine serotypes increased among persons aged 2 years and older. CONCLUSIONS: In the 2 years since licensure, widespread PCV vaccination of children has resulted in dramatic declines in the proportion of antibiotic-nonsusceptible isolates in Tennessee. PCV vaccination of children also appears to be a highly effective method for reducing the burden of IPD in adults.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Increasing Prevalence of Multidrug-Resistant Streptococcus pneumoniae in the United States
Whitney, C. G., Farley, M. M., Hadler, J., Harrison, L. H., Lexau, C., Reingold, A., Lefkowitz, L., Cieslak, P. R., Cetron, M., Zell, E. R., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012283432603 · Cited by 888 · cited 1×
“Serotyping was also performed for available isolates identified after 1997, as described elsewhere [1, 8].”
MethodEffectiveness of Pneumococcal Polysaccharide Vaccine in Older Adults
Jackson, L. A., Neuzil, K. M., Yu, O., Benson, P., Barlow, W. E., Adams, A. L., Hanson, C. A., Mahoney, L. D., Shay, D. K., & Thompson, W. W. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022678 · Cited by 608 · cited 1×
“Licensed in 1977, the 23-valent polysaccharide vaccine (PPV), which contains purified capsular antigens for 23 pneumococcal serotypes, reduces the risk of pneumococcal bacteremia in vaccinated individuals aged 2 years and older but is ineffective in younger children and does not decrease the rate of noninvasive pneumo…”
Background
Cited by
Antimicrobial resistance: a global multifaceted phenomenon
Prestinaci, F., Pezzotti, P., & Pantosti, A. (2015) · Pathogens and Global Health · doi:10.1179/2047773215y.0000000030 · Cited by 3,296
Kyaw, M. H., Lynfield, R., Schaffner, W., Craig, A. S., Hadler, J., Reingold, A., Thomas, A. R., Harrison, L. H., Bennett, N. M., Farley, M. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051642 · Cited by 881
Self-citationWhitney, C. G., Pilishvili, T., Farley, M. M., Schaffner, W., Craig, A. S., Lynfield, R., Nyquist, A.-C., Gershman, K. A., Vazquez, M., Bennett, N. M., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69637-2 · Cited by 623
Self-citationEffect of Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis
Hsu, H. E., Shutt, K. A., Moore, M. R., Beall, B. W., Bennett, N. M., Craig, A. S., Farley, M. M., Jorgensen, J. H., Lexau, C. A., Petit, S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0800836 · Cited by 497
Self-citationPoehling, K. A., Talbot, T. R., Griffin, M. R., Craig, A. S., Whitney, C. G., Zell, E., Lexau, C. A., Thomas, A. R., Harrison, L. H., Reingold, A. L., et al. (2006) · JAMA · doi:10.1001/jama.295.14.1668 · Cited by 463
Self-citationAsthma as a risk factor for invasive pneumococcal disease
Talbot, T. R., Hartert, T. V., Mitchel, E., Halasa, N. B., Arbogast, P. G., Poehling, K. A., Schaffner, W., Craig, A. S., & Griffin, M. R. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044113 · Cited by 395
Self-citationAntimicrobial resistance in gram-positive bacteria
Rice, L. B. (2006) · American Journal of Infection Control · doi:10.1016/j.ajic.2006.05.220 · Cited by 381
Pichichero, M. E., & Casey, J. R. (2007) · JAMA · doi:10.1001/jama.298.15.1772 · Cited by 367
The clinical consequences of antimicrobial resistance
Rice, L. B. (2009) · Current Opinion in Microbiology · doi:10.1016/j.mib.2009.08.001 · Cited by 291
Antimicrobial Resistance in Gram-Positive Bacteria
Rice, L. B. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.03.012 · Cited by 276
Halasa, N. B., Shankar, S. M., Talbot, T. R., Arbogast, P. G., Mitchel, E. F., Wang, W. C., Schaffner, W., Craig, A. S., & Griffin, M. R. (2007) · Clinical Infectious Diseases · doi:10.1086/516781 · Cited by 253
Self-citationFarrell, D. J., Klugman, K. P., & Pichichero, M. (2007) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000253059.84602.c3 · Cited by 221
“This study demonstrates that pneumococcal serotype distribution has changed significantly in the 4 years after the introduction of PCV7.”
BackgroundInfluential
Metadata
- Authors
- Talbot, T. R., Poehling, K. A., Hartert, T. V., Arbogast, P. G., Halasa, N. B., Ed, M., Schaffner, W., Craig, A. S., Edwards, K. M., & Griffin, M. R.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-09-01
- Volume
- 39
- Issue
- 5
- Pages
- 641-648
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2162583094
- Cited by
- 134
- References
- 2
- FWCI
- 13.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.